(VIANEWS) – The NASDAQ ended the session with Exact Sciences (EXAS) rising 6.45% to $39.80 on Thursday while NASDAQ rose 1.67% to $12,639.27.

Exact Sciences Corporation offers cancer screening and diagnostic products both in the United States as well internationally. Cologuard is a stool-based, non-invasive DNA screening test that detects DNA and hemoglobin biomarkers in colorectal and pre-cancer. Oncotype DX is a test that detects gene expression in breast, colon, and prostate cancers. It also offers Oncotype Test which provides tumor profiling for therapy selections for patients suffering from advanced, metastatic or recurrent cancers. Oncotype DX AR–V7 Nucleus Test for advanced stage prostate carcinoma. Oncomap ExTra provides an extensive biological picture for certain rare and aggressive cancers. Its products include a pipeline of products that improve the performance characteristics of the Cologuard test and develop blood- and fluid-based tests. Hologic, Inc. and MAYO Foundation for Medical Education and Research have license agreements. Exact Sciences Corporation, which was established in 1995, is located in Madison (Wisconsin).


Today’s last reported volume for Exact Sciences is 2591640, 18.62% above its average volume of 2184720.

Exact Sciences’s last close was $37.39, 65.69% under its 52-week high of $108.99.

Exact Sciences’s Sales

Exact Sciences’s sales growth is 10.2% for the current quarter and 6.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 12.4% and positive 5.5% for the next.

Exact Sciences’s Revenue

Year-on-year quarterly revenue growth grew by 21%, now sitting on 1.85B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Exact Sciences’s stock is considered to be oversold (<=20).

Exact Sciences’s Stock Yearly Top and Bottom Value

Exact Sciences’s stock is valued at $39.80 at 19:05 EST, way under its 52-week high of $108.99 and way higher than its 52-week low of $35.34.

Exact Sciences’s Moving Average

Exact Sciences’s worth is below its 50-day moving average of $43.51 and way below its 200-day moving average of $64.39.

More news about Exact Sciences (EXAS).


Please enter your comment!
Please enter your name here